The burgeoning field of weight management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These novel therapies represent a significant https://hannaldps789372.wikicorrespondence.com/5939443/glp_3_receptor_agonists_retatrutide_trizepatide